Actelion is on track...
Message to Shareholders
Highlights
People
Addresses
Product Status
TracleerŽ - Worldwide Marketing
TracleerŽ - The Endothelin Receptor Antagonist
TracleerŽ - New hope for patients
Launch of ZavescaŽ
Development - Promising clinical data
Development - Addressing unmet medical needs
Drug Discovery Research
CFO's Letter
Corporate Governance
Consolidated Financial Statements - Report of the Group Auditors
Consolidated Financial Statements
Notes to the Consolidated Financial Statements
Holding Company Statements - Report of the Statutory Auditors
Holding Company Statements
Holding Company Statements - Notes to the Financial Statements
Shareholder Information
Actelion 2002
Products
Financial Statements
Actelion 2002
THE ACTELION ANNUAL REPORT 2002
Actelion is on track...
Message to Shareholders
Highlights
People
Addresses
Home
Contact
Actelion.com
Legal Disclaimer
